Laboratory Studies for Diagnosing Hereditary Hemochromatosis, Marfan Syndrome, and Ehlers-Danlos Syndrome
Hereditary Hemochromatosis Diagnostic Testing
For diagnosing hereditary hemochromatosis, initial laboratory testing should include serum ferritin and transferrin saturation, followed by genetic testing for HFE mutations in patients with abnormal iron studies. 1
Initial Iron Studies:
- Transferrin saturation (calculated as serum iron divided by total iron binding capacity × 100) with values >45% suggesting hemochromatosis 2, 3
- Serum ferritin levels with values >200 μg/L in women or >300 μg/L in men suggesting iron overload 1, 4
- Both tests should be performed simultaneously as transferrin saturation is typically the earliest and most sensitive marker of hemochromatosis 2
Genetic Testing:
- HFE gene mutation analysis for C282Y and H63D mutations should be performed when iron studies are abnormal 2
- C282Y mutation is present in approximately 90% of patients with hereditary hemochromatosis, with most being homozygous for this mutation 1, 2
- Compound heterozygotes (C282Y/H63D) can also develop iron overload, though less commonly 1
Additional Testing:
- Liver function tests (ALT, AST) to assess for hepatic involvement 2
- Liver biopsy may be indicated in C282Y homozygotes with serum ferritin >1,000 μg/L, elevated liver enzymes, or age >40 years to assess for cirrhosis 2
- Hepatic iron concentration measurement by liver biopsy is considered the gold standard but is less commonly used with the advent of genetic testing 1
Testing Algorithm for Hereditary Hemochromatosis:
- Measure serum ferritin and transferrin saturation 1
- If transferrin saturation >45% or ferritin is elevated (>200 μg/L in women, >300 μg/L in men), proceed to HFE genetic testing 2, 4
- If genetic testing confirms C282Y homozygosity, the diagnosis is established 2
- For compound heterozygotes or those with negative genetic testing but persistent iron overload, consider liver biopsy or MRI to quantify hepatic iron 2, 3
Marfan Syndrome Diagnostic Testing
While the provided evidence doesn't specifically address Marfan syndrome testing, based on general medical knowledge:
- FBN1 gene testing is the primary laboratory test for Marfan syndrome
- Fibrillin-1 protein analysis may be performed in specialized laboratories
- Transforming growth factor beta (TGF-β) pathway biomarkers may be evaluated in research settings
Ehlers-Danlos Syndrome Diagnostic Testing
Similarly, the provided evidence doesn't specifically address Ehlers-Danlos syndrome testing, but based on general medical knowledge:
- Genetic testing for specific subtypes (COL5A1, COL5A2 for classical EDS; COL3A1 for vascular EDS)
- Collagen typing from skin biopsy in specialized laboratories
- Tenascin-X testing for hypermobility type
Important Clinical Considerations
- Before genetic testing, patients should be counseled about the risks, benefits, and limitations, including potential impacts on insurability and psychological well-being 1
- Common causes of hyperferritinemia should be excluded before attributing elevated levels to hemochromatosis, including chronic alcohol consumption, inflammatory conditions, and non-alcoholic fatty liver disease 2
- Family screening is recommended for first-degree relatives of patients diagnosed with hemochromatosis 2
- A single elevated transferrin saturation measurement should be confirmed with repeat testing due to diurnal variations 3
- Early diagnosis and treatment of hemochromatosis before organ damage occurs can prevent disease manifestations and allow normal life expectancy 4, 5
Pitfalls to Avoid:
- Relying on a single test for diagnosis; both transferrin saturation and serum ferritin should be measured 2
- Failing to consider secondary causes of elevated iron studies before diagnosing hereditary hemochromatosis 2
- Overlooking the need for genetic testing in first-degree relatives of affected individuals 2, 6
- Misinterpreting ferritin levels, which can be elevated due to inflammation, liver disease, or other conditions unrelated to iron overload 2, 7